Regulating AGI without a crisp definition: a false-positive tradeoff argument
davidmanheim · x · 2026-09-16
David Manheim debates whether AGI's ill-defined nature blocks regulation. Critics argue regulation needs measurable targets, citing radioactive-material and drug controls. Manheim counters that a blurry boundary isn't fatal: rules can trade higher false positives for low-enough false negatives. He adds that existing systems clearly fall outside AGI under such definitions, and the hard part—future edge cases—is also what matters most.
More from AGI Musings
- Robin Hanson on why the world wisely ignores long-term problems — sebkrier · 2026-09-16
- Ex-OpenAI researcher puts 70% odds on globally catastrophic AI outcomes — ccerrato147 · 2026-09-16
- BackOps AI raises $42M Series B six months after $26M Series A to automate logistics ops — HankYeomans · 2026-09-16
- Heidy Khlaaf in the Guardian: AI extinction claims are unfalsifiable and unscientific — GaryMarcus · 2026-09-16
- DeepMind launches Institute with essays from Hassabis, Legg on AGI governance and reasoning transparency — sebkrier · 2026-09-16
- Brendan McCord launches Cosmos Ventures to back 'philosopher-builders' for the AI age — lawhsw · 2026-09-16